Opdivo
- Strength
- 100mg/ 10ml/ 40mg/ 4ml
- Manufacturer
- BRISTOL-MYERS SQUIBB Pharma
- Availability
- Available to source
Nivolumab 100mg/ 10ml/ 40mg/ 4ml — Injection, 1's Vial
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
Opdivo uses and dosage
Opdivo (Nivolumab), is a prescription medicine used to treat lung cancer, head and neck squamous cell cancer, skin cancer (called melanoma), kidney cancer, classical Hodgkin lymphoma (a type of blood cancer), urothelial carcinoma (bladder cancer), liver cancer, colorectal cancer. Opdivo manufactured by BRISTOL-MYERS SQUIBB Pharma in USA. Nivolumab has to inject slowly into a vein over 30 to 60 minutes, usually once every 2 to 4 weeks.
Indications
Opdivo side effects
The most common adverse reactions of Nivolumab are: Diarrhea, fever, fatigue, shortness of breath, decreased appetite, cough, nausea, constipation, rash, stomach/ abdominal pain, mouth/ throat sores, vomiting, unusual weakness, headache, pain in muscles, bones, and joints.
- Originator brand
- OPDIVO by Bristol-Myers Squibb
- Made by
- BRISTOL-MYERS SQUIBB Pharma
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.
